Robbins LLP Urges HIMS Stockholders Who Lost Money Investing in Hims & Hers Health, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is soliciting lead-plaintiff candidates for a securities class action against Hims & Hers Health covering purchasers of HIMS securities between August 4, 2025 and July 29, 2026, with a November 2, 2026 lead plaintiff deadline. The complaint alleges the company shared consumers' protected health information with third-party advertising platforms including Meta and Snap, and charged customers for prescriptions almost immediately after intake-form submission, exposing it to regulatory scrutiny. The class action follows the FTC's July 29, 2026 lawsuit against Hims over privacy and billing practices; on that news the stock fell $4.32, or 14.73%, to close at $25.00.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.